Email

yl10@bcm.edu

Positions

Associate Professor

Medicine - Epidemiology & Population Sciences
Dan L Duncan Comprehensive Cancer Center
Baylor College of Medicine
Houston, Texas, United States

Addresses

Baylor College of Medicine (Office)

One Baylor Plaza
Jewish Bldg 619D
Houston, TX, 77030
United States
Phone: (713) 798-2956

Professional Interests

• Cancer Epidemiology and Genetics
• Risk prediction, early detection and treatment response
• Molecular Biomarkers (genomic, microbiota, and immunological)

Websites

Selected Publications

• Liu Y, Ajami NJ, El-Serag HB, et al. " Dietary quality and the colonic mucosa-associated gut microbiome in humans " Am J Clin Nutr. 2019 Sep ; 110 (3) : 701-712.
  Pubmed PMID: 31291462.
• Wefel JS, Zhou R, Sulman EP ... Liu Y (corresponding). " Genetic modulation of longitudinal change in neurocognitive function among adult glioma patients " J Neurooncol.. 2022 Jan ; 156 (1) : 185-193.
  Pubmed PMID: 34817796.
• Liu Y, Kramer JR, Sandulache VC, et al. " Immunogenetic Determinants of Susceptibility to Head and Neck Cancer in the Million Veteran Program Cohort " Cancer Res.. 2023 Feb 3; 386-397.
  Pubmed PMID: 36378845.
• Liu Y, O'Brien JL, Ajami NJ, et al.. " Lung tissue microbial profile in lung cancer is distinct from emphysema " J Cancer Res.. 2018 ; 8 (9) : 1775-1787.
  Pubmed PMID: 30323970.
• Liu Y, Xia J, McKay J, et al. " Rare deleterious germline variants and risk of lung cancer " NPJ Precis Oncol. 2021 Feb 16;
  Pubmed PMID: 33594163.

Show 1 more publications

Memberships

American Association of Cancer Research (AACR)

Active member (01/2013)

International Association for the Study of Lung Cancer (IASLC)

Active member (06/2015)

American Society of Human Genetics (ASHG)

(05/2016)

Society for Immunotherapy of Cancer (SITC)

Active member (12/2024)

Funding

Intratumoral microbiota and immune predictors of response to immunotherapy in lung cancer

(08/01/2024 - 07/31/2029)

Grant funding from NCI R01CA285882

Identifying germline pathogenic variants in familial lung cancer among African Americans

(03/01/2024 - 02/28/2026)

Grant funding from NCI R03CA282953

Evaluating etiological impact of metatranscriptomic and immunological features for lung cancer

(07/01/2021 - 06/30/2023)

Grant funding from NCI R03CA262911

Lung Cancer Prediction Models Incorporating Exome Data from Extreme Phenotypes

(09/01/2014 - 08/31/2019)

Grant funding from NCI K07CA181480

Left vs Left Randomized Clinical Trial

(01/01/2023 - 06/30/2029)

Unrestricted funding from PCORI

Sequencing familial lung cancer

(01/20/2020 - 06/30/2025)

Grant funding from NCI R01CA243483